[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369727-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369727-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bilosomal-encapsulation-of-binuclear-phosphino-ruii-cuii-compounds-enhances-their-selectivity-and-activity-toward-lung-and-prostate-cancers","Bilosomal Encapsulation of Binuclear Phosphino Ru(II)−Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers","","The study reports synthesis, structural characterization, and biological evaluation of four novel heteronuclear Ru(II)−Cu(II) complexes bearing phosphine–fluoroquinolone conjugates. Stability and coordination geometries are verified by X-ray diffraction, density functional theory, and spectroscopic analyses. Cytotoxicity is assessed in vitro across lung, breast, pancreatic, prostate, and noncancerous cell lines, with in vivo toxicity evaluated using zebrafish (Danio rerio) larvae. Compared with cisplatin, Ru(II)−Cu(II) complexes show higher anticancer activity and near-nontoxic behavior toward control cells, with apoptosis-linked mechanisms and improved stability and selectivity upon bilosomal encapsulation in 3D spheroid models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bilosomal-encapsulation-of-binuclear-phosphino-ruii-cuii-compounds-enhances-their-selectivity-and-activity-toward-lung-and-prostate-cancers/369727/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bilosomal-encapsulation-of-binuclear-phosphino-ruii-cuii-compounds-enhances-their-selectivity-and-activity-toward-lung-and-prostate-cancers/369727.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What types of compounds are synthesized and evaluated in this study?","Question",{"text":63,"@type":64},"Four novel heteronuclear Ru(II)−Cu(II) complexes with phosphine–fluoroquinolone conjugates are synthesized and subjected to structural and biological evaluation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is anticancer activity assessed in vitro and in vivo?",{"text":68,"@type":64},"In vitro cytotoxicity is tested across multiple cancer cell lines (including lung, breast, pancreatic, and prostate) and noncancerous cells. In vivo toxicity is evaluated using zebrafish (Danio rerio) larvae.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanisms are proposed for how the Ru(II)−Cu(II) complexes kill cancer cells?",{"text":72,"@type":64},"Mechanistic studies indicate nuclei accumulation, reactive oxygen species generation, lipid peroxidation, mitochondrial membrane depolarization, and apoptotic cell death supported by Bax/Bcl-2 mRNA expression ratio changes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369727,1790213878,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/jmc](pubs.acs.org/jmc)  Article   \nBilosomal Encapsulation of Binuclear Phosphino Ru(II)−Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers  \nSandra Kozieł, * Daria Wojtala, Agata Barzowska-Gogola, Barbara Pucelik, Ewelina Waglewska, Miłosz Siczek, Maciej Witwicki, Alessandro Niorettini, Agnieszka Kyzioł, Magdalena Malik, Urszula Bazylínska, Ewa Błaszczak, and Urszula K. Komarnicka *  \n Cite This: J. Med. Chem. 2025, 68, 14442−14464  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: This study reports the synthesis, characterization, and biological evaluation of four novel heteronuclear Ru(II)−Cu(II) complexes with phosphine−fluoroquinolone conjugates. Structural analysis using X-ray diffraction, density functional theory calculations, and various spectroscopic techniques confirmed the stability and coordination geometries. The cytotoxicity was evaluated in vitro across multiple cancer cell lines (lung, breast, pancreatic, prostate) and noncancerous cells. In vivo toxicity was also assessed using azebrafish (Danio rerio) larvae model. The results demonstrated that Ru(II)−Cu(II) complexes exhibit greater anticancer activity compared with cisplatin while almost being nontoxic toward control cells in vitro. Mechanistic studies revealed that their action involves nuclei accumulation, reactive oxygen species generation, lipid peroxidation, and mitochondrial membrane depolarization. The expression ratio of Bax to Bcl-2 mRNA correlates with apoptotic cell death. Additionally, encapsulation of the one Ru(II)−Cu(II) complex in bilosomes significantly improved its stability, selectivity, and therapeutic efficacy in three-dimensional (3D) cancer spheroid models.  \n■ INTRODUCTION  \nCancer is still the second leading cause of morbidity and mortality worldwide. 1−5 Considering the effectiveness ofcisplatin and its derivatives in chemotherapy, other transitionmetal complexes, including those based on Ru, Ir, Rh, Pd, Cu, and Os, have emerged as a new generation of promising anticancer agents. They not only exhibit a variety of anticancer mechanisms but can also overcome the resistance and side effects of traditional Pt-based anticancer drugs.6,7 Among them, half-sandwich ruthenium(II) complexes have rapidly emerged as potential therapeutic agents due to their unique anticancer mechanisms, such as mitochondrial activity inhibition, protein kinase inhibition,8,9 induction ofendoplasmic reticulum stress,10 and induction of apoptosis.11 Moreover, it has been demonstrated that organometallic arene complexes are more likely to target cellular metabolism rather than, for instance, DNA, which is a well-established target ofcisplatin (CDDP).12 Some of these complexes also showed antiangiogenic properties, allowing them to inhibit angiogenesis, a key process underlying tumor growth and metastasis.13 The several ruthenium(III)-based compounds named (i) NAMI-A, imidazolium [ transtetrachloro(1H-imidazole)(S-dimethyl sulfoxide)ruthenate-(III)],14, 15 (ii) KP1019, indazolium [trans-tetrachlorobis(1H-  \nindazole)ruthenate(III)], 16−19 as well as (iii) NKP-1339, sodium trans-[tetrachloridobis(1H-indazole)ruthenate-(III)] 16,20 were examined in different phases of the clinical trials as agents with potential use in chemotherapy.21−23 These compounds are often termed drug precursors. Detailed studies of these Ru(III) coordination complexes have shown that they require activation􀀁conversion from Ru(III) prodrugs to more reactive Ru(II) drugs􀀁or reduction by ascorbic acid or glutathione molecules to acquire anticancer properties. It is assumed that the reduction occurs only in cancerous cells due to their increased acidity and low oxygen concentration (hypoxia).22,24,25  \nBesides the aforementioned ruthenium drugs, ruthenium − arene complexe","cbCaiaNnJLQsAU9i","https://ap.wps.com/l/cbCaiaNnJLQsAU9i","pdf",10080284,23,"English","# Abstract\n# Introduction\n## Background and motivation\n## Ru(II)-arene and related anticancer agents\n## Heteropolymetallic strategy and rationale","[{\"question\":\"What types of compounds are synthesized and evaluated in this study?\",\"answer\":\"Four novel heteronuclear Ru(II)−Cu(II) complexes with phosphine–fluoroquinolone conjugates are synthesized and subjected to structural and biological evaluation.\"},{\"question\":\"How is anticancer activity assessed in vitro and in vivo?\",\"answer\":\"In vitro cytotoxicity is tested across multiple cancer cell lines (including lung, breast, pancreatic, and prostate) and noncancerous cells. In vivo toxicity is evaluated using zebrafish (Danio rerio) larvae.\"},{\"question\":\"What mechanisms are proposed for how the Ru(II)−Cu(II) complexes kill cancer cells?\",\"answer\":\"Mechanistic studies indicate nuclei accumulation, reactive oxygen species generation, lipid peroxidation, mitochondrial membrane depolarization, and apoptotic cell death supported by Bax/Bcl-2 mRNA expression ratio changes.\"}]","Bilosomal Encapsulation of Binuclear Phosphino Ru(II)−Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers | PDF",1790184238,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ba82d653b6fb43ae6fa5efd0ad1bc30.webp",983,1296,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01791f74efabe10e93f1d40508f9aa16.webp",982,1295,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d75eaa3f412c8c76fe4c2f7478fcc994.webp",981,1293,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c4c46329e5195841b69f14a00d5d7b2.webp",980,1292]